Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
Rs. Crores · hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales 109.21
219.35
141.50
103.60
109.32
118.87
77.76
47.52
87.53
74.71
43.74
37.11
43.10
Expenses 108.67
209.98
135.54
100.30
106.86
116.97
76.56
47.45
86.72
73.09
42.66
35.26
40.65
Operating Profit 0.54
9.37
5.96
3.30
2.46
1.90
1.20
0.07
0.81
1.62
1.08
1.85
2.45
OPM % 0.49
4.27
4.21
3.19
2.25
1.60
1.54
0.15
0.93
2.17
2.47
4.99
5.68
Other Income 0.05
0.00
0.00
0.01
0.01
0.02
0.02
0.00
0.01
0.15
0.01
0.00
0.00
Depreciation 1.56
1.73
0.82
0.76
0.76
0.91
0.68
0.68
0.68
0.67
0.74
0.70
0.68
Interest 0.49
2.04
0.17
0.01
0.04
0.00
0.04
0.03
0.00
0.01
0.11
0.03
0.10
Profit before tax -1.46
5.60
4.97
2.54
1.67
1.01
0.50
-0.64
0.14
1.09
0.24
1.12
1.67
Tax % 15.07
68.93
15.90
25.59
0.00
54.46
0.00
0.00
0.00
123.85
0.00
0.00
0.00
Net Profit -1.67
1.74
4.17
1.90
1.67
0.46
0.50
-0.64
0.14
-0.26
0.23
1.12
1.68
EPS in Rs -0.34
0.36
0.96
0.44
0.38
0.11
0.13
-0.16
0.04
-0.07
0.06
0.28
0.42
Annual · Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
574.00 332.00 199.00 114.00 59.00 68.00 77.00 93.00 67.00 13.00 4.00 11.00
Expenses
553.00 328.00 192.00 105.00 58.00 73.00 77.00 89.00 63.00 12.00 5.00 14.00
Operating Profit
21.00 4.00 7.00 9.00 1.00 -5.00 0.00 4.00 3.00 0.00 -1.00 -3.00
OPM %
3.70 1.20 3.50 8.00 0.90 -7.00 -0.10 4.40 4.50 0.40 -24.00 -23.00
Other Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest
2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00
Depreciation
4.00 3.00 3.00 3.00 3.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00
Profit before tax
15.00 1.00 4.00 6.00 -2.00 -7.00 -2.00 2.00 1.00 -2.00 -3.00 -5.00
Tax %
26.00 54.00 33.00 27.00 -22.00 -24.00 -16.00 50.00 43.00 -30.00 -27.00 -26.00
Net Profit
11.00 0.00 3.00 5.00 -2.00 -6.00 -2.00 1.00 0.00 -1.00 -2.00 -4.00
EPS in Rs
2.23 0.11 0.69 1.13 -0.59 -2.07 -0.79 0.32 0.17 -0.75 -1.13 -1.94
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
49.00 44.00 40.00 32.00 23.00 22.00 19.00 19.00 16.00 16.00 16.00 16.00
Reserves
73.00 48.00 17.00 -10.00 -16.00 -15.00 -10.00 -8.00 -8.00 -10.00 -8.00 -6.00
Borrowings
0.00 0.00 0.00 2.00 2.00 16.00 17.00 16.00 20.00 22.00 27.00 28.00
Other Liabilities
169.00 126.00 107.00 69.00 51.00 55.00 36.00 35.00 29.00 16.00 12.00 13.00
Total Liabilities
292.00 217.00 164.00 93.00 60.00 77.00 62.00 62.00 58.00 44.00 47.00 51.00
Fixed Assets
68.00 53.00 31.00 31.00 32.00 30.00 28.00 27.00 29.00 30.00 32.00 34.00
CWIP
0.00 0.00 4.00 0.00 0.00 1.00 1.00 0.00 0.00 1.00 1.00 1.00
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
224.00 164.00 129.00 62.00 28.00 46.00 34.00 35.00 28.00 14.00 15.00 16.00
Total Assets
292.00 217.00 164.00 93.00 60.00 77.00 62.00 62.00 58.00 44.00 47.00 51.00
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
8.00 -10.00 -26.00 -8.00 1.00 4.00 3.00 -2.00 0.00 6.00 0.00 1.00
Cash from Investing Activity
-20.00 -22.00 -6.00 -2.00 -1.00 -4.00 -4.00 2.00 0.00 0.00 0.00 0.00
Cash from Financing Activity
18.00 34.00 32.00 11.00 0.00 0.00 0.00 0.00 0.00 -7.00 -1.00 -2.00
Net Cash Flow
6.00 2.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.00
Free Cash Flow
-11.00 -32.00 -32.00 -10.00 -2.00 -1.00 0.00 -2.00 -1.00 6.00 0.00 1.00
CFO/OP %
54.00 -238.00 -348.00 -79.00 107.00 -40.00 -3,456.00 -24.00 9.00 12,760.00 -53.00 -56.00
Annual · Days / % — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
92.00 99.00 126.00 135.00 21.00 31.00 47.00 21.00 47.00 124.00 272.00 187.00
Inventory Days
41.00 81.00 107.00 61.00 152.00 199.00 110.00 104.00 80.00 182.00 868.00 228.00
Days Payable
112.00 143.00 198.00 158.00 186.00 221.00 175.00 131.00 151.00 424.00 870.00 290.00
Cash Conversion Cycle
21.00 36.00 34.00 38.00 -14.00 9.00 -19.00 -7.00 -24.00 -119.00 271.00 124.00
Working Capital Days
29.00 39.00 54.00 48.00 -15.00 -1.00 -36.00 -20.00 -50.00 -319.00 -564.00 -139.00
ROCE %
16.00 1.00 11.00 38.00 -12.00 -29.00 -8.00 7.00 3.00 -6.00 -8.00 -11.00
% holding — latest first
Quarterly
Yearly
Holder
Jul 2026
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Promoters
63.38
60.15
60.86
56.71
56.71
56.71
57.02
53.17
53.17
53.89
53.89
53.89
DIIs
0.15
0.16
0.16
0.18
0.18
0.18
0.18
0.20
0.20
0.25
0.25
0.14
Public
36.47
39.70
38.97
43.11
43.11
43.11
42.79
46.63
46.63
45.87
45.86
45.97
No. of Shareholders
12,825
12,809
12,855
12,836
13,273
12,906
13,223
13,445
13,305
13,310
13,942
12,571
2 records